The U.S. Food and Drug Administration has approved drug labeling changes to six menopausal hormone therapy products, also known as hormone replacement therapy (HRT), to clarify risk considerations for these drugs.
FDA News Releases published a clinical update in Research Highlights on 12 Feb 2026. The item focuses on FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. Open the detail page to review the full original feed content.